Transchem Ltd (TRANSCHEM) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 500422 | NSE: TRANSCHEM | Agriculture | Small Cap

Transchem Share Price

122.11 5.81 5.00%
as on 05-Dec'25 16:59

Transchem Ltd (TRANSCHEM) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 500422 | NSE: TRANSCHEM | Agriculture | Small Cap

DeciZen - make an informed investing decision on Transchem

Based on:

Overall Rating
Login to view analysis. M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Transchem stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
37.55
Market Cap:
142.4 Cr.
52-wk low:
31.1
52-wk high:
116.3

Is Transchem Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Transchem: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Transchem Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 0.1%-0.6%-1.5%2.1%2.1%49.7%6.1%3.8%8%9.1%-
Value Creation
Index
-1.0-1.0-1.1-0.9-0.92.6-0.6-0.7-0.4-0.4-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 0000022.5000.42.63
Sales YoY Gr.-NANANANANA-100%NANA541.5%-
Adj EPS -0.9-1.1-1.50.10.319.72.313.443.1
YoY Gr.-NANANA135.7%5878.8%-88.1%-56.8%239.6%16.3%-
BVPS (₹) 31.43130.1313051.454.253.861.864.866.2
Adj Net
Profit
-1.1-1.3-1.80.20.424.22.91.24.24.94
Cash Flow from Ops. 1.10.6-19.810.3-0.6-27.721.91.2-39.336-
Debt/CF from Ops. 0000000000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANANA541.5%
Adj EPS NA64.6%19.5%16.3%
BVPS8.4%16.6%6.2%4.9%
Share Price 21.4% 54.3% 69.6% 171.9%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
-2.9-3.4-4.90.41.148.54.41.95.96.34.7
Op. Profit
Mgn %
0000091.400-423.4-55.7-31.4
Net Profit
Mgn %
00000107.5001025.2185.5144.3
Debt to
Equity
00000000000
Working Cap
Days
000004570040,2467,099721
Cash Conv.
Cycle
00000100183209718

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Transchem Ltd.

Standalone Consolidated
TTM EPS (₹) 3.1 -
TTM Sales (₹ Cr.) 2.6 -
BVPS (₹.) 66.2 -
Reserves (₹ Cr.) 69 -
P/BV 1.76 -
PE 37.55 -
From the Market
52 Week Low / High (₹) 31.10 / 116.30
All Time Low / High (₹) 2.55 / 105.50
Market Cap (₹ Cr.) 142
Equity (₹ Cr.) 12.2
Face Value (₹) 10
Industry PE 29.3

Management X-Ray of Transchem:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Transchem - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Transchem

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales00000220003
Operating Expenses 1121123224
Manufacturing Costs0000000000
Material Costs0000000003
Employee Cost 0000111111
Other Costs 1111112111
Operating Profit -1-1-2-1-121-3-2-2-1
Operating Profit Margin (%) -----91.4%---423.0%-55.7%
Other Income 2223347479
Interest 0000000000
Depreciation 1111100000
Exceptional Items 0000000000
Profit Before Tax 0-0-111254367
Tax 0010011112
Profit After Tax 0-0-100243145
PAT Margin (%) -----107.5%--1,025.2%198.7%
Adjusted EPS (₹)0.0-0.2-1.00.30.319.72.31.03.44.3
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 38383738376366667679
Share Capital 12121212121212121212
Reserves 26262526255154546367
Minority Interest0000000000
Debt0000000000
Long Term Debt0000000000
Short Term Debt0000000000
Trade Payables0000000000
Others Liabilities -0-000001010
Total Liabilities 38383738376367667680

Fixed Assets

Gross Block38776600000
Accumulated Depreciation30122200000
Net Fixed Assets 7654400000
CWIP 0000000000
Investments 2830106499892
Inventories1100000000
Trade Receivables0000000003
Cash Equivalents flag 1001616123434042
Others Assets 002112134324236733
Total Assets 38383738376367667680

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 11-2010-1-28221-3936
PBT 0-0-111254367
Adjustment 11111-22-0-0-0-1
Changes in Working Capital 0-0-219-1-2919-0-4432
Tax Paid 00-0-0-1-1-1-1-1-2
Cash Flow From Investing Activity -0-22061231-156
Capex -0-00002600-01
Net Investments -1-22051-31-155
Others 0000000000
Cash Flow From Financing Activity 0000000000
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid 0000000000
Dividend Paid 0000000000
Others 0000000000
Net Cash Flow 1-1-0160-5230-3442

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)0.12-0.57-3.180.821.148.444.441.875.946.74
ROCE (%)0.12-0.57-1.472.072.1249.696.053.797.999.12
Asset Turnover Ratio000000.45000.010.03
PAT to CFO Conversion(x)N/AN/AN/AN/AN/A-1.177.331-9.757.2
Working Capital Days
Receivable Days00000000365216
Inventory Days0000010000
Payable Days00000000019

Transchem Ltd Stock News

Transchem Ltd FAQs

The current trading price of Transchem on 05-Dec-2025 16:59 is ₹122.1.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Transchem stood at ₹142.3.
The latest P/E ratio of Transchem as of 04-Dec-2025 is 37.55.
The latest P/B ratio of Transchem as of 04-Dec-2025 is 1.76.
The 52-week high of Transchem is ₹116.3 and the 52-week low is ₹31.10.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Transchem is ₹2.63 ( Cr.) .

About Transchem Ltd

Transchem limited is a professionally managed, public limited company, the API manufacturing operations were started in 1993. The company is reputed as quality conscious manufacturer and exporter of specialized high quality API's and pharmaceutical intermediates.

The company is the largest producer of widest range of Anathematic API's (Anti-Parasitic) in the world, manufactured under one roof in WHO GMP accredited facility. It also offers specialized range of human use API’s.

The company is having four state of the art GMP approved facilities at multiple locations in India, with total production capacity of 500 MT per annum.

The company is one of the largest suppliers of Albendazole, Clorsulon, Diminazene Diaceturate, Toldimfos Sodium, Oxfendazole, Fenbendazole, Flubendazole, Mebendazole, Nitroxynil, Ramipril from India and can meet all the requiered technical and quality aspects of esteemed organizations and is now focusing on Anti-Hypertensive and Anti-Diabetic range of products.

Products and services offered by the company:

Services:

  • Contract Research Facility.
  • Custom Synthesis of Molecules.
  • Contract Manufacturing of API's as per GMP Guidelines.
  • Intermediates.
  • Veterinary Formulations.
  • Q.A. & Regulatory Support.

Product:

Anthelmintics

  • Albendazole USP / EP /BP
  • Ricobendazole (Albendazole Sulphoxide)
  • Mebendazole EP / BP / USP / POLY 'C'
  • Oxyclozanide BP VET
  • Closantel Sodium EP / BASE
  • Clorsulon USP
  • Nitroscanate
  • Fenbendazole EP/BP/BP VET
  • Oxfendazole BP VET / EP
  • Flubendazole EP / 98%
  • Nitroxynil BP VET
  • Rafoxanide BP VET
  • Triclabendazole
  • Praziquantel BP / USP

Veterinary API's

  • Diminazene Diaceturate B VET C
  • Quinapyramine Salts B VET C
  • Parvaquone
  • Toldimfos Sodium
  • Acepromazine Maleate BP VET
  • Butaphosphan
  • Flunixin Meglumine USP
  • Homidium Bromide / Chloride
  • Isometamedium

Ectoparaciticides

  • Cyromazine.
  • Cymiazole
  • S-Methoprene
  • Azamethiphos.

Human Use API's

  • Ramipril EP
  • Frusemide EP / BP / USP
  • Gabapentin USP
  • Cetirizine DI HCL EP/BP
  • Lamotrigine
  • Pentamidine Isetionate BP
  • Succinylcholine Chloride USP
  • Epinastine HCL
  • Nifuroxazide
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×